Olo Power Eye Drop 0.7% (Olopatadine Hydrochloride), Olo Power Eye Drop 0.7% (Olopatadine Hydrochloride) (single use)
Olopatadine Hydrochloride 7.76mg
Eye drops · Prescription medication
Hankook Pharmaceutical Co., Ltd.
MFDS item code 202007457 · Approved 2020.10.30 · Insurance code 645306451,645306721
Relief of allergic conjunctivitis (itchy eyes)
This medication treats itchy eyes caused by allergic conjunctivitis, alleviating discomfort and reducing inflammation to improve symptoms. It effectively relieves itching and redness, helping to protect the patient's ocular health. This medication is also used to manage allergic reactions and prevent recurrence, thus helping to improve symptoms of itchy eyes and allergic conjunctivitis.
[Multi-use] Instill 1 drop once a day. [Single-use] Instill 1 drop once a day. Discard any remaining liquid and container immediately after use.
This medication should not be used by individuals who are allergic to the active ingredient or any of the components. Using this medication may cause symptoms such as blurred vision, dryness, small damage to the cornea, or unusual sensations in the eyes. Additionally, the phosphate component in this medication may rarely cause calcification in the cornea of patients with severe corneal injury. Contact lenses should not be worn while the eyes are red, and if using contact lenses, they should not be put on for at least 5 minutes after instilling this medication. This medication is a non-sedating antihistamine; however, it may temporarily blur vision after use, so one should wait until vision is clear before driving or operating machinery. Patients undergoing long-term steroid treatment should gradually reduce the steroid dosage when using this medication, and this process should be done under the supervision of healthcare professionals. For patients with seasonal allergies, it is advisable to begin using this medication before the onset of symptoms and to continue using it until symptoms resolve. If it proves ineffective, long-term use should be avoided for safety. This medication is an eye drop intended for ophthalmic use only and should not be used as an injection or orally. Pregnant women should carefully consider the risks to the fetus versus the benefits of using this medication, and lactating women should also consider potential effects on the baby. The safety and efficacy of this medication in children under 2 years of age have not been established, so caution is warranted. Elderly patients can use this medication without any specific differences compared to younger individuals. When using this medication, care should be taken to prevent the tip of the container from coming into direct contact with the eye, and the container should be securely closed after use to prevent contamination. Single-use products should be used only once after opening, and it is recommended to discard the first 1-2 drops. This medication should be stored out of reach of children, in a cool place, away from direct sunlight, and should not be transferred to another container. In animal studies, this medication showed no potential for carcinogenicity or mutagenicity, and any effects on reproductive function were observed only at high doses.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is important to store it at a cool temperature between 2°C and 25°C to maintain its efficacy.
[Multi-use] An eye drop solution in an opaque white container with a colorless to light yellow liquid, [Single-use] An eye drop solution in a colorless to light yellow liquid contained in a colorless transparent plastic container
[Multi-use] 2.5mL/bottle, [Single-use] 0.4mL/10 vials
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 7.76mg
Eye drops · Prescription medication
Hankook Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.